Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Save this search Download search results Subscribe to news feed Your filters: cql: author="Van Schil, PE" or (type exact bookEditor and editor="Van Schil, PE") Add to list Journal Article A1 Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial PE Van Schil, P Baas, R Gaafar, AP Maat, M Van de Pol, B Hasan, HM Klomp, AM Abdelrahman, J Welch and JP van Meerbeeck (2010) EUROPEAN RESPIRATORY JOURNAL. 36(6). p.1362-1369 Add to list Conference Paper C3 Pemetrexed (P) and Cisplatin (C) as either Induction (IC) or Adjuvant (AC) Chemotherapy in stage IB-II Non-Small Cell Lung Cancer (NSCLC): A randomized phase 2 study (EORTC 08051) Jan Van Meerbeeck (UGent) , P Germonpre, Frank Vermassen (UGent) , J Welch and PE Van Schil (2009) JOURNAL OF THORACIC ONCOLOGY. 4(9). p.S791-S791 Add to list Conference Paper C3 Toxicity of EORTC 08031: phase 11 feasibility trial of induction chemotherapy (ICT) followed by extrapleural pneumonectomy (EPP) and postoperative radiotherapy (PORT) for malignant pleural mesothelioma (MPM) cT3N1M0 or less PE Van Schil, P Baas, R Gaafar, AP Maat, M van de Pol, B Hasan, HM Klomp, AM Abdelrahman, J Welch and Jan Van Meerbeeck (UGent) (2009) JOURNAL OF THORACIC ONCOLOGY. 4(9). p.S322-S322 Add to list Conference Paper C3 Does downstaging in patients (pts) with IIIA-N2 non-small cell lung cancer (NSCLC) and a response to induction chemotherapy (ICT) influence outcome with surgery (S) or radiotherapy (RT)? An exploratory analysis of EORTC 08941 Jan Van Meerbeeck (UGent) , GW KRAMER, C LEGRAND, EF SMIT, A PASSIOUKOV, G GIACCONE, N VAN ZANDWIJK and PE VAN SCHIL (2006) JOURNAL OF CLINICAL ONCOLOGY. 24(18).